KCM
VKTX icon

Kornitzer Capital Management’s Viking Therapeutics VKTX Stock Holding History

Kornitzer Capital Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.07M Buy
+155,662
New +$5.03M 0.13% 165

Other funds holding VKTX

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
IFWM
Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
LA
LBP AM Paris, France $10B AUM 43.88% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Kornitzer Capital Management's VKTX Position: Q2 2026 in Review

Kornitzer Capital Management opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 155,662 shares worth $6.07M. The stake represents 0.13% of the portfolio and ranks #165 among its holdings.

123 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Kornitzer Capital Management held 155,662 shares of Viking Therapeutics worth $6.07M as of Q2 2026.
  • Viking Therapeutics was a new Kornitzer Capital Management position in Q2 2026.
  • Viking Therapeutics made up 0.13% of Kornitzer Capital Management's portfolio in Q2 2026, its #165 holding.
  • 123 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.